tibolone has been researched along with Adenocarcinoma, Endometrioid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cummings, SR; Ettinger, B; Johnson, SR; Kenemans, P; Mol-Arts, M; Seifert, W; Van Os, S; Verweij, PJ | 1 |
| Arteaga-Gómez, AC; Castellanos-Barroso, G; Colin-Valenzuela, A; García-Vargas, J; Márquez-Acosta, G; Reyes-Muñoz, E | 1 |
1 trial(s) available for tibolone and Adenocarcinoma, Endometrioid
| Article | Year |
|---|---|
Endometrial effects of tibolone in elderly, osteoporotic women.
Topics: Aged; Bone Density Conservation Agents; Carcinoma, Endometrioid; Endometrial Neoplasms; Endometrium; Estrogen Replacement Therapy; Female; Humans; Hyperplasia; Metrorrhagia; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal | 2008 |
1 other study(ies) available for tibolone and Adenocarcinoma, Endometrioid
| Article | Year |
|---|---|
[Hormone therapy effect in postmenopausal women with history of endometrial cancer].
Topics: Adenocarcinoma; Adult; Carcinoma, Adenosquamous; Carcinoma, Endometrioid; Comorbidity; Diabetes Mellitus, Type 2; Endometrial Neoplasms; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Follow-Up Studies; Humans; Hypertension; Middle Aged; Neoplasm Staging; Norpregnenes; Postmenopause; Recurrence; Retrospective Studies; Smoking | 2011 |